recast-jats-buildd8e1462159jitcJ Immunother Cancer40425Journal for ImmunoTherapy of CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltds40425-019-0571-757110.1186/s40425-019-0571-730940188/jitc/7/1/94.atomCorrectionCorrection to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapyYaoHang-Ping1FengLiang23SutheSreedhar Reddy3ChenLing-Hui45WengTian-Hao1HuChen-Yu1JunEun Sung67WuZhi-Gang4WangWei-Lin45iKimSong Cheol7jTongXiang-Min8kWangMing-Hai134l 0000 0004 1803 6319grid.452661.2State Key Laboratory for Diagnosis & Treatment of Infectious DiseasesFirst Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China Cancer Biology Research Center Hangzhou China grid.412425.4Department of Pharmaceutical SciencesTexas Tech University Health Sciences Center School of Pharmacy Amarillo TX USA Zhejiang Provincial Key Laboratory for Precision Diagnosis & Treatment of Hepatic & Pancreatic Oncology Hangzhou Zhejiang Province China 0000 0004 1803 6319grid.452661.2Division of Hepatobiliary & Pancreatic SurgeryFirst Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China 0000 0004 0533 4667grid.267370.7Department of Convergence Medicine, Asan Institute for Life SciencesUniversity of Ulsan College of Medicine and Asan Medical Center Seoul Republic of Korea 0000 0001 0842 2126grid.413967.eDivision of Hepato-Biliary and Pancreatic Surgery, Department of SurgeryUniversity of Ulsan College of Medicine, Asan Medical Center Seoul Republic of Korea 0000 0004 1798 6507grid.417401.7Department of Laboratory MedicineZhejiang Provincial People’s Hospital, Hangzhou Medical College Hangzhou China wam@zju.edu.cn drksc@amc.seoul.kr tongxiangmin@163.com minghai.wang@ttuhsc.edu 1220192420191811201918112019242019719420320192032019© The Author(s).2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Following publication of the original article [1], the author reported two errors in the authors affiliations:

publisher-imprint-nameBioMed Centralvolume-issue-count1issue-article-count0issue-toc-levels0issue-pricelist-year2019issue-copyright-holderThe Author(s)issue-copyright-year2019article-contains-esmNoarticle-numbering-styleUnnumberedarticle-registration-date-year2019article-registration-date-month3article-registration-date-day19article-toc-levels0toc-levels0volume-typeRegularjournal-productArchiveJournalnumbering-styleUnnumberedarticle-grants-typeOpenChoicemetadata-grantOpenAccessabstract-grantOpenAccessbodypdf-grantOpenAccessbodyhtml-grantOpenAccessbibliography-grantOpenAccessesm-grantOpenAccessonline-firstfalsepdf-file-referenceBodyRef/PDF/40425_2019_Article_571.pdfpdf-typeTypesettarget-typeOnlinePDFissue-typeRegulararticle-typeErratumjournal-subject-primaryMedicine & Public Healthjournal-subject-secondaryOncologyjournal-subject-secondaryImmunologyjournal-subject-collectionMedicine

The original article can be found online at 10.1186/s40425-019-0525-0

Correction to: J Immunother Cancer 2019 7:75

https://doi.org/10.1186/s40425-019-0525-0

Following publication of the original article [1], the author reported two errors in the authors affiliations:

1. Dr. Song Cheol Kim should be affiliated to Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery,University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea;

2. Dr. Eun Sung Jun should be affiliated to Department of Convergence Medicine, Asan Institute for Life Sciences, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea and to Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery,University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea;

Reference Yao et al. Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy. Journal for ImmunoTherapy of Cancer. 2019;7:75 doi:10.1186/s40425-019-0525-0